WASHINGTON — Pfizer and BioNTech said on Tuesday that they had sought emergency authorization for a second booster shot of their coronavirus vaccine for adults 65 and older.The companies’ request to the Food and Drug Administration was based heavily on data from Israel, where such shots are authorized for a somewhat broader group. Their move…
